raloxifene hydrochloride has been researched along with cycloheximide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Jang, JJ; Kim, BC; Kim, HT; Kim, IY; Kim, SJ; Mamura, M; Seong, DH | 1 |
| Li, H; Li, X; Liu, S; Lu, S; Luo, M; Zhang, T | 1 |
3 other study(ies) available for raloxifene hydrochloride and cycloheximide
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; bcl-Associated Death Protein; bcl-X Protein; Carrier Proteins; Caspase 3; Caspases; Cell Division; Cell Membrane; Cell Nucleus; Cycloheximide; Cytochrome c Group; DNA Fragmentation; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Humans; In Situ Nick-End Labeling; Membrane Potentials; Mitochondria; Phosphorylation; Protein Binding; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Raloxifene Hydrochloride; Retroviridae; Time Factors; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2002 |
A matrix dispersion based on phospholipid complex system: preparation, lymphatic transport, and pharmacokinetics.
Topics: Administration, Oral; Animals; Biological Availability; Bone Density Conservation Agents; Calorimetry, Differential Scanning; Chylomicrons; Cycloheximide; Drug Liberation; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Models, Animal; Osteoporosis, Postmenopausal; Particle Size; Phospholipids; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators; Solubility; Tablets; X-Ray Diffraction | 2020 |